Blockade of CXCR4 with neutralizing antibodies prevented the BC cell line MDA-MB-231 from metastasizing to the liver and lung as these organs express the CXCR4 ligand, CXCL12 (SDF-1). Here, CXCL12 is linked to breast cancer.